Graft-versus-host disease in murine bone marrow transplantation. II. Modulation of acute and chronic GVHD in mice receiving bone marrow allografts pretreated with immunosuppressive factor derived from a human T cell line-Reference-Cited by-同舟云学术

Graft-versus-host disease in murine bone marrow transplantation. II. Modulation of acute and chronic GVHD in mice receiving bone marrow allografts pretreated with immunosuppressive factor derived from a human T cell line

Published:1985-01 Issue:5-6 Volume:11 Page:293-299
ISSN:0165-2478
Container-title:Immunology Letters
language:en
Short-container-title:Immunology Letters

Author:

Gorczynski Reginald M.,Lau Catherine Y.,Robillard Maria

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference15 articles.

1. Cellular Immunology and the Pathogenesis of Graft Versus Host Reactions (Part 1 of 3)

2. Chronic graft-versus-host syndrome in man

3. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.

4. EXPONENTIAL RELATIONSHIP BETWEEN SPLEEN CELL CONCENTRATION AND FATAL GRAFT-VERSUS-HOST RESPONSE AFTER TRANSPLANTATION OF ALLOGENEIC SPLEEN-MARROW CELL MIXTURES

5. BONE MARROW TRANSPLANTATION ACROSS MAJOR HISTOCOMPATIBILITY BARRIERS IN MICE EFFECT OF ELIMINATION OF T CELLS FROM DONOR GRAFTS BY TREATMENT WITH MONOCLONAL THY-1.2 PLUS COMPLEMENT OR ANTIBODY ALONE

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INDUCTION OF NATURAL SUPPRESSOR-LIKE CELLS FROM HUMAN ADULT PERIPHERAL BLOOD LYMPHOCYTES BY A K562-DERIVED FACTOR;Transplantation;1993-06

2. Spermine dialdehyde, a novel ex vivo purging agent for both allogeneic and autologous bone marrow transplantations;International Journal of Immunopharmacology;1992-08

3. Role of aldehyde dehydrogenase in the biological activity of spermine dialdehyde, a novel immunosuppressive/purging agent;Pharmacological Research;1992-05

4. Specific manipulation in vivo of immunity to skin grafts bearing multiple minor histocompatibility differences;Immunology Letters;1991-02

5. Purification, characterization, and structural elucidation of the active moiety of the previously called “suppressor activating factor (SAF)”;Cellular Immunology;1990-01